Ligand Pharmaceuticals Inc. (LGND)

Health Care·equity

$301.81

+2.31% today

Extended hours $302.31

Prices delayed about 15 minutes · cached page, can be an hour old or more

Market Census Score

59/ 100

Score level

Above average

6 of 6 checks had data

Smart-money score is on the low side — score for how it compares with the broader market is near the top of its range, while price trend score is on the high side.

LGND scores higher than 84% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, Ligand Pharmaceuticals Inc. (LGND) scores 59 out of 100 on the Market Census six-factor composite, which puts it at the Above average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated 9 October 2026 · scores usually change about once a day

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume: 0.75× 30-day average
52-week range: 175.89 – 326.63
Market cap: $5.65B
Earnings date: 5 Nov 2026

Volume: 183,043
Avg. volume (30d): 243,928

Open: 294.79
Previous close: 295.00
Day's range (regular session): 294.31 – 304.77

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta: 1.23
P/E (TTM): 29.64
EPS (TTM): 9.40

Score breakdown · six named factors

Price trend

Strength vs the market

Company finances

Insider trades

Market mood

Recent momentum

Each bar is one part of the score, from 0 to 100. Read what the score means.

Premium data held for LGND

33 SEC Form 4 insider transactions in the last 90 daysPremium

Counts of rows Market Census holds for LGND. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans

What the score says about LGND right now

Ligand Pharmaceuticals Inc. (LGND) currently scores 59/100 on the Market Census six-factor composite, at the Above average score level. LGND is +2.31% on the day and -0.27% over five sessions as of the most recent tick. Above average sits a bit above the middle. The data for LGND leans good, with some weak spots. LGND's strongest factor is strength vs the market at 81/100 — a very strong read on how LGND has done next to the wider market. It describes what has happened, not what happens next. The weakest factor is insider trades at 20/100 — a well below average read on insider buying and selling. Insider filings for LGND lean toward selling; on a thinly filed name a few filings can set this reading.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See LGND in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Create your account →Share on X Embed this score